Document is current
Any future updates will be listed below
-
Authors
Grinda, Thomas
Aizer, Ayal A.
Lin, Nancy U.
Sammons, Sarah L.
- License Information
-
More Information
Article History
Accepted: 4 December 2024
First Online: 9 January 2025
Declarations
:
: TG discloses Travel fees from AstraZeneca, Gilead, and Pfizer. Consulting/Advisor role for AstraZeneca and a personal Grant from the Philippe Foundation. AA notes research funding from Varian and NH TherAguix as well as consulting for Novartis and Seagen.NUL declares consulting honorarium from Seagen, Daichii-Sankyo, AstraZeneca, Olema Pharmaceuticals, Janssen, Blueprint Medicines, Stemline/Menarini, Artera Inc., Eisai; travel support from Olema Pharmaceuticals; research support (to institution) from Genentech, Zion Pharmaceuticals (as part of GNE), Pfizer, Seagen, Merck, Olema Pharmaceuticals, AstraZeneca; royalties from Up To Date.SS declares research funding to their institution from Astra Zeneca, Eli Lilly, Relay, SEAGEN and Sermonix; and consulting fees from Foundation Medicine, Astra Zeneca, Daichii Sankyo, Eli Lilly, Pfizer, Incyclix, Relay, Gilead, Sermonix and Novartis.
: This article does not contain any studies with human or animal subjects performed by any authors.
